Ozempic May Blunt Metabolic Effects of Antipsychotics

(MedPage Today) — A GLP-1 receptor agonist may help improve metabolic profiles for certain schizophrenia patients on antipsychotics, the randomized HISTORI trial indicated.
Among 154 schizophrenia patients with prediabetes and overweight or obesity…

Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/117292

Author :

Publish date : 2025-09-03 18:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Ozempic May Blunt Metabolic Effects of Antipsychotics

ADHD Meds and Psychosis; RFK Jr. Targets SSRIs; 1B People Have Psych Disorders

Plant-based dog foods provide almost all the nutrients pets need

Related Posts

RFK Jr. ‘Diss Track’; Med Student Qualifies for Olympic Trials; Infant Formula PSA

Two Drugs Approved for NPM1-Mutated Leukemia

Second Menin Inhibitor Approved for Mutated R/R AML

Here’s What RFK Jr., FDA Got Wrong About Menopausal Hormone Therapy

Inside the UK’s Battle Against Counterfeit Drugs

Pediatrician Killed in Crash; Neurosurgeon’s Gun Arrest; Army Ob/Gyn Lawsuit

RFK Jr. ‘Diss Track’; Med Student Qualifies for Olympic Trials; Infant Formula PSA

Second Menin Inhibitor Approved for Mutated R/R AML

Here’s What RFK Jr., FDA Got Wrong About Menopausal Hormone Therapy

Inside the UK’s Battle Against Counterfeit Drugs

Pediatrician Killed in Crash; Neurosurgeon’s Gun Arrest; Army Ob/Gyn Lawsuit

Noninvasive Imaging Test Provides Answers in Angina With No Obstructive Arteries

A simple hack to help you switch off after work

Ultraprocessed Foods Tied to Early Colorectal Adenoma Risk

Categories

Archives